67 studies found for:    Open Studies | "Antiretroviral Therapy, Highly Active" OR HAART
Show Display Options
Rank Status Study
21 Unknown  Atorvastatin for HAART Suboptimal Responders
Condition: Acquired Immune Deficiency Syndrome Virus
Interventions: Other: 'atorvastatin, Lipitor®';   Drug: Placebo
22 Recruiting Use of Incentives to Retain Drug Users in HIV Therapy
Condition: HIV Infection
Intervention: Other: monetary reinforcer
23 Recruiting Switch to Darunavir/r + Maraviroc Quaque Die in Patients With R5 Tropism by Viral DNA Genotyping (GUSTA)
Condition: HIV Infection
Interventions: Drug: Maraviroc, Darunavir/r;   Drug: current antiretroviral therapy with 3 drugs
24 Unknown  Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Therapy (HAART) in HIV/HCV Coinfected Antiretroviral (ARV) Naive Patients Starting Treatment With Anti-HCV Therapy
Conditions: HIV Infections;   Hepatitis C
Interventions: Drug: LPV/r;   Drug: Nucleoside Reverse Transcriptase Inhibitors;   Drug: PEG-IFNa 2a;   Drug: Ribavirin
25 Recruiting Effect of HIV Infection and Highly Active Antiretroviral Treatment (HAART) on Bone Homeostasis
Conditions: HIV Infection;   Osteopenia;   Osteoporosis
Intervention:
26 Recruiting Dose Escalation Study of Cyclophosphamide in HIV-Infected Subjects on HAART Receiving SB-728-T
Condition: HIV
Intervention: Genetic: SB-728-T
27 Unknown  Optimal Time to Initiate Antiretroviral Therapy in HIV & TB Coinfected Adults Being Treated for Tuberculosis
Conditions: Acquired Immunodeficiency Syndrome;   Tuberculosis
Intervention: Other: Comparison of different treatment strategies
28 Unknown  Metabolic Safety of Raltegravir Versus Darunavir in HIV Naive Patients
Conditions: Cardiovascular Disease;   HIV Infections
Intervention:
29 Unknown  Nevirapine Clearance After Short-term Highly Active Antiretroviral Therapy (HAART) for Prevention of Mother to Child Transmission of HIV (PMTCT)
Conditions: NVP Plasma Level;   NVP Related Mutation;   3TC Related Mutation
Intervention: Drug: AZT/3TC 2 weeks after delivery
30 Unknown  Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Therapy (HAART) in HIV/HCV Coinfected Patients Starting Treatment With Anti-Hepatitis C Virus (HCV) Therapy
Conditions: HIV Infections;   Hepatitis C
Interventions: Drug: LPV/r;   Drug: PEG-IFNa 2a;   Drug: Ribavirin;   Drug: NUCS
31 Recruiting Maraviroc Abacavir STudy - Effect on Endothelial Recovery
Condition: Endothelial Dysfunction
Intervention: Drug: Maraviroc
32 Recruiting Reducing Heavy Drinking to Optimize HIV/AIDS Treatment and Prevention
Condition: Reduction in Heavy Drinking in Patients With HIV
Interventions: Drug: Naltrexone;   Other: Placebo + Medication Management/Medication Coaching
33 Recruiting Trends of Morbidity and Mortality Among Thai HIV-infected and HIV-uninfected Patients: a Five-year Prospective Cohort Study
Conditions: HIV Infection;   Healthy
Intervention:
34 Recruiting Management of Highly Active Anti-retroviral Therapy-related Hyperlipidemia Among HIV-infected Patients in Taiwan
Condition: HIV
Intervention:
35 Unknown  SHARE: Simple HAART With Abacavir, Reyataz, and Epivir
Conditions: HIV Infections;   Lipodystrophy
Interventions: Drug: atazanavir (Reyataz);   Drug: ritonavir (Norvir)
36 Unknown  Intralesional Bevacizumab for Treating AIDS-associated Kaposi´s Sarcoma of the Larynx, Pharynx and Oral Cavity
Condition: Kaposi´s Sarcoma
Intervention: Drug: Bevacizumab
37 Recruiting Medication Adherence in Human Immunodeficiency Virus (HIV)
Condition: Human Immunodeficiency Virus
Interventions: Behavioral: Staff-delivered intervention sessions;   Other: Demographic Questionnaire;   Other: Questionnaires
38 Recruiting Adherence & Health Outcome Differences Amongst HIV Infected Patients Prescribed HAART
Conditions: Acquired Immunodeficiency Syndrome;   Human Immunodeficiency Virus Type
Intervention:
39 Not yet recruiting Strategies for the Prevention of Hepatitis B Among HIV Infected Patients in Uganda
Condition: HIV/AIDS and Infections
Intervention: Biological: Hepatitis B vaccine
40 Recruiting Repeat Doses of SB-728mR-T After Cyclophosphamide Conditioning in HIV-Infected Subjects on HAART
Condition: Human Immunodeficiency Virus (HIV)
Interventions: Genetic: SB-728mR-T;   Drug: Cyclophosphamide

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years